Company said last month: "Initial preliminary study results are anticipated in 4th quarter 2017."
Quick look back at clinicaltrial.org: - Treatment takes 3 weeks, estimated study and primary end date are Dec 31. - Monitoring of adverse events: 6 weeks - Other outcomes take 1-3 weeks, including RNA analysis
This is why I suspect we get final results in 1H'18. Depends on final participant enrollment date of course.